Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
Nippon India Pharma Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 05-Jun-04
Corpus(Cr.) 9166.00 Latest NAV 552.3717 As on 29-10-2026
Equity(%) 97.31 52 Week High 581.042
Debt(%) 2.69 52 Week Low 481.825
Others(%) 0.00 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Sailesh Raj Bhan
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 36.44%
Top 10 Holdings 56.35%
Top 25 Holdings 89.37%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 73.97
Healthcare 20.81
Cash 2.69
Retail 2.53
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.29
PE Ratio 38.49
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Ltd. 11.71
Divis Laboratories Ltd. 7.10
Lupin Ltd 6.17
Cipla Ltd. 6.01
Dr. Reddys Laboratories Ltd. 5.45
Apollo Hospitals Enterprises Ltd. 4.89
Mankind Pharma Limited 4.38
Sai Life Sciences Limited 3.92
Ajanta Pharma Ltd. 3.61
GlaxoSmithkline Pharmaceuticals Ltd. 3.11
Ipca Laboratories Ltd. 2.87
Triparty Repo 2.81
Max Healthcare Institute Limited 2.70
Vijaya Diagnostic Centre Limited 2.62
Medplus Health Services Limited 2.53
Gland Pharma Limited 2.53
Abbott India Ltd. 2.32
PIRAMAL PHARMA LIMITED 2.24
Thyrocare Technologies Limited 2.24
Dr. Lal Pathlabs Limited 2.17
Alkem Laboratories Limited 1.82
Aurobindo Pharma Ltd. 1.65
Narayana Hrudayalaya Limited 1.61
SURAKSHA DIAGNOSTIC LIMITED 1.51
Syngene International Limited 1.40

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-3.00% -3.30% 6.77% 7.07%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-2.23% -2.98% 8.71% 8.99%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
4.35% 17.32% 13.04% 14.09%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
6.75% 21.05% 14.18% 10.60%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Nippon India Pharma Fund (G) 15.06% -0.4122 13.4397% 48.8498 -0.0056
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Nippon India Pharma Fund (G) -7.2897% 0.6808 -0.1111 15.5040 -0.6140
 
Back to Selection